445 related articles for article (PubMed ID: 28875852)
1. Molecular Modeling Studies of Novel Fluoroquinolone Molecules.
Allaka TR; Katari NK; Veeramreddy V; Anireddy JS
Curr Drug Discov Technol; 2018; 15(2):109-122. PubMed ID: 28875852
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Biological Evaluation of Novel Heterocyclic Fluoroquinolone Citrate Conjugates as Potential Inhibitors of Topoisomerase IV: A Computational Molecular Modeling Study.
Allaka TR; Katari NK; Jonnalagadda SB; Malkhed V; Anireddy JS
Curr Drug Discov Technol; 2021; 18(6):e130921187682. PubMed ID: 33155923
[TBL] [Abstract][Full Text] [Related]
4. New Fluoroquinolone-1,2,4-triazoles as Potent Antibacterial Agents: Design, Synthesis, Docking Studies and in Silico ADME Profiles.
Rao Gollapalli V; Babu Bollikolla H; Rao Allaka T; Ranga Rao Vaddi P; Basireddy S; Ganivada M; Reddy Pindi S
Chem Biodivers; 2023 Apr; 20(4):e202201259. PubMed ID: 36924103
[TBL] [Abstract][Full Text] [Related]
5. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
7. Docking and 3D QSAR Studies on Substituted Cyclobutylphenyl Quinoline Derivatives as Inhibitors of Bacterial DNA Gyrase.
Wani RR; Chaudhari HK
Curr Comput Aided Drug Des; 2018; 14(4):322-337. PubMed ID: 29766821
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent.
Patel MM; Patel LJ
ScientificWorldJournal; 2014; 2014():897187. PubMed ID: 25574496
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
[TBL] [Abstract][Full Text] [Related]
10. Combined QSAR/QSPR and molecular docking study on fluoroquinolones to reduce biological enrichment.
Zhao X; Zhao Y; Ren Z; Li Y
Comput Biol Chem; 2019 Apr; 79():177-184. PubMed ID: 30836319
[TBL] [Abstract][Full Text] [Related]
11. New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus.
Samir M; Ramadan M; Abdelrahman MH; Elbastawesy MAI; Halby HM; Abdel-Aziz M; Abuo-Rahma GEA
Bioorg Med Chem; 2022 Nov; 73():117004. PubMed ID: 36148773
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
Patel MM; Patel LJ
Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
[TBL] [Abstract][Full Text] [Related]
13. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.
Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P
J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275
[TBL] [Abstract][Full Text] [Related]
15. Cluster-based molecular docking study for in silico identification of novel 6-fluoroquinolones as potential inhibitors against Mycobacterium tuberculosis.
Minovski N; Perdih A; Novic M; Solmajer T
J Comput Chem; 2013 Apr; 34(9):790-801. PubMed ID: 23280926
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
Alagumuthu M; Arumugam S
Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.
Madurga S; Sánchez-Céspedes J; Belda I; Vila J; Giralt E
Chembiochem; 2008 Sep; 9(13):2081-6. PubMed ID: 18677735
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
[TBL] [Abstract][Full Text] [Related]
19. Structure based drug discovery and in vitro activity testing for DNA gyrase inhibitors of Salmonella enterica serovar Typhi.
Sharma P; Kumar M; Dahiya S; Sood S; Das BK; Kaur P; Kapil A
Bioorg Chem; 2020 Nov; 104():104244. PubMed ID: 32966903
[TBL] [Abstract][Full Text] [Related]
20. Chrysin based pyrimidine-piperazine hybrids: design, synthesis, in vitro antimicrobial and in silico E. coli topoisomerase II DNA gyrase efficacy.
Patel KB; Rajani D; Ahmad I; Patel H; Patel HD; Kumari P
Mol Divers; 2023 Jun; ():. PubMed ID: 37318711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
